Jazz Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Jazz Pharmaceuticals's estimated annual revenue is currently $2.9B per year.
- Jazz Pharmaceuticals's estimated revenue per employee is $840,435
- Jazz Pharmaceuticals's total funding is $2B.
- Jazz Pharmaceuticals's current valuation is $8.9B. (January 2022)
Employee Data
- Jazz Pharmaceuticals has 3403 Employees.
- Jazz Pharmaceuticals grew their employee count by 8% last year.
Jazz Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.4M | 2 | 0% | N/A | N/A |
#2 | $32M | 159 | 3% | N/A | N/A |
#3 | $35M | 121 | 3% | $62.5M | N/A |
#4 | $30.2M | 150 | 18% | N/A | N/A |
#5 | $135.3M | 673 | 0% | N/A | N/A |
#6 | $14.9M | 113 | 16% | $173M | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Jazz Pharmaceuticals?
We are a pharmaceutical company focusing on improving the lives of patients through the development and commercialization of neurological and psychiatric products. We are committed to working closely with patients, patient advocacy groups and healthcare professionals.
keywords:N/A
$2B
Total Funding
3403
Number of Employees
$2.9B
Revenue (est)
8%
Employee Growth %
$8.9B
Valuation
N/A
Accelerator
Jazz Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Chairman | Reveal Email/Phone |
2 | Executive Director | Reveal Email/Phone |
3 | Training & Development Operations Manager | Reveal Email/Phone |
4 | Executive Assistant, Commercial Management | Reveal Email/Phone |
5 | Associate Director, Global Medical and Promotional Regulatory Affairs | Reveal Email/Phone |
6 | VP, Global Clinical Development Operations | Reveal Email/Phone |
7 | Senior Medical Science Liaison | Reveal Email/Phone |
8 | Director, Translational Science | Reveal Email/Phone |
9 | Drug Safety Evaluation - Toxicologist | Reveal Email/Phone |
10 | Head Stock Plan Services | Reveal Email/Phone |
Jazz Pharmaceuticals News
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients...
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz...
DUBLIN, Aug. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2021 and affirmed non-GAAP adjusted financial guidance for 2021. "As we enter what we expect to be a period of sustained growth, I have never been more excite ...
DUBLIN, July 13, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Tuesday, July 20, 2021 at 4:30 p.m. ET / 9:30 p.m. IST to provide an update on Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn), which was approved ...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $697.1M | 3434 | -20% | N/A |
#2 | $698.9M | 3566 | -20% | N/A |
#3 | $1061.6M | 3639 | 3% | $563.8M |
#4 | $1471.2M | 3892 | 2% | N/A |
#5 | $1125.5M | 4594 | 4% | N/A |